Trial intelligence / Profile preview

Restasis in Heavy Computer Users With Dry Eye Disease

NCT00567177Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Nov 2007
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine in dry eye disease (DED), sponsored by Janssen Pharmaceutical. Started Nov 2007; status: completed.

02

Drugs

cyclosporine
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT00567177.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00567177.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call